SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Incyte (INCY)
INCY 65.63+0.4%10:46 AM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (3122)4/14/2017 3:40:27 PM
From: tuck  Read Replies (2) of 3202
 
EMA Analysis of Baracitinib h/t to Peter. Neither he nor PGS can find anything untoward. The PR makes it sound pretty bad, as if another trial has to be done. Not sure if we'd have to wait for that to be hashed out and hinted at in the protocol, or if management at Lilly/Incyte will provide details at the next public Q&A. Because they will surely be asked. Wondering if the fear should be bought here.

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext